ISG15 and sarcoma: Taken together, results of these experiments suggest that high expression levels of ISG15, NUP50, PTTG1, SERPINE1, and TSR1 exert a positive regulatory effect on metastasis, suggesting poor prognosis, and that Tanespimycin may effectively treat LMS sarcoma subtype.